Kura Oncology (KURA) Payables (2010 - 2026)
Kura Oncology (KURA) posted quarterly Payables of $7.0 million for Q1 2026, down 84.38% year-over-year from $45.1 million in Q1 2025, and up 40.38% quarter-over-quarter from $5.0 million in Q4 2025.
Kura Oncology (KURA) Payables (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has reported Payables for 17 consecutive years, with $7.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 84.38% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $7.0 million (down 84.38% YoY), while the FY2025 annual figure was $5.0 million, up 241.52% from the prior year.
- Payables advanced to $7.0 million in Q1 2026 per KURA's latest filing, from $5.0 million in the prior quarter.
- Across five years, Payables topped out at $66.8 million in Q3 2025 and bottomed at $1.3 million in Q1 2022.
- Historically, Payables has averaged $24.3 million across 5 years, with a median of $21.7 million in 2022.
- Annual changes were most pronounced in 2023 — Payables jumped 1164.1% — and 2024, when it plunged 95.65%.
- Kura Oncology's Payables stood at $21.7 million in 2022, then jumped by 55.28% to $33.8 million in 2023, then slumped by 95.65% to $1.5 million in 2024, then jumped by 241.52% to $5.0 million in 2025, then surged by 40.38% to $7.0 million in 2026.
- Business Quant data shows KURA's Payables at $7.0 million in Q1 2026, $5.0 million in Q4 2025, and $66.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Kura Oncology | 966.11 Mn | 966.11 Mn | 20.63 Mn | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.39 Mn |
| Mar 31, 2026 | 7.04 Mn |
| Dec 31, 2025 | 5.02 Mn |
| Sep 30, 2025 | 66.79 Mn |
| Jun 30, 2025 | 52.93 Mn |
| Mar 31, 2025 | 45.09 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 36.97 Mn |
| Jun 30, 2024 | 31.14 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | 33.76 Mn |
| Sep 30, 2023 | 25.84 Mn |
| Jun 30, 2023 | 21.55 Mn |
| Mar 31, 2023 | 16.90 Mn |
| Dec 31, 2022 | 21.74 Mn |
| Sep 30, 2022 | 22.44 Mn |
| Jun 30, 2022 | 15.58 Mn |
| Mar 31, 2022 | 1.34 Mn |
| Dec 31, 2021 | 20.19 Mn |
| Sep 30, 2021 | 2.88 Mn |